
A phase I and zzso study of a novel zzso zzso zzso zzso zzso ethane zzso zzso has been carried out on two zzso zzso zzso zzso continuous zzso In schedule I, doses of zzso zzso per day were zzso zzso toxicity was zzso but zzso and zzso skin zzso zzso zzso zzso zzso and zzso were also zzso In schedule II, doses of 192 and 240 zzso were zzso zzso toxicity was zzso but zzso toxicity was also zzso zzso starting doses for phase II studies are 75 zzso per day for 5 days or 192 zzso by continuous infusion for 24 zzso zzso studies indicated a zzso plasma zzso of zzso h and a large and variable volume of zzso 

